DR1 and colorectal carcinoma: Mutagenesis of the 5′FR was expected to reduce the affinity of PPARα to the PPRE (i.e. a rightward shift in the CRC), whereas mutagenesis of the DR1 was expected to generally reduce PPAR affinity to the promoter [16–18].